DICLOFENAC SODIUM

Posted by: Admin

To receive automatic updates of Nursing News, Nursing Care Plans, Case Studies and the much awaited November 2008 Nursing Board Exam Result: click Subscribe to NursingCrib.com by Email or via RSS. If you have other topics to discuss, make a post on our Nursing Crib Forum. Thanks for visiting and enjoy your stay!




(di-klo’fen-ak)
Voltaren, Voltaren-XR, Solaraze
DICLOFENAC POTASSIUM

Cataflam
Classifications:
central nervous system agent; analgesic, antipyretic; nsaid
Prototype: Ibuprofen
Pregnancy Category: B

NURSING IMPLICATIONS

Assessment & Drug Effects

  • Monitor for therapeutic effectiveness. Up to 3 wks may be needed for beneficial effects with rheumatoid arthritis or osteoarthritis.
  • Lab tests: Periodic liver function, serum uric acid concentrations Hct, PT/INR, and blood glucose.
  • Observe and report signs of bleeding (e.g., petechiae, ecchymoses, bleeding gums, bloody or black stools, cloudy or bloody urine).
  • Monitor BP for hypertension and blood sugar for hyperglycemia.
  • Monitor diabetics closely for loss of diabetic control.
  • Monitor for increased serum sodium and potassium in patients receiving potassium-sparing diuretics.
  • Monitor weight and report gains greater than 1 kg (2 lb)/24 h.
  • Monitor for signs and symptoms of GI irritation and ulceration.

Patient & Family Education

Oral Form

  • Do not lie down for 15–30 min after taking medicine to decrease esophageal irritation.
  • Discontinue use with onset of ringing or buzzing in the ears, impaired hearing, dizziness, GI discomfort, or bleeding and notify physician.
  • Do not take aspirin or other OTC analgesics without permission of the physician.
  • Avoid alcohol or other CNS depressants.
  • Do not drive or engage in other potentially hazardous activities until reaction to drug is known.
  • Note: Diabetics need to monitor blood glucose carefully for loss of glycemic control.
  • Do not breast feed while taking this drug.


Print This Post Print This Post
Email This Post Email This Post



_____________________________________________________________________________________________

  • ENOXAPARIN (e-nox’a-pa-rin) Lovenox Classifications: blood formers, coagulators, and anticoagulants; low molecular weight heparin Pregnancy Category: B NURSING IMPLICATIONS Assessment & Drug Effects Lab tests: Baseline coagulation studies; periodic CBC, platelet count, urine and stool for occult blood. Monitor platelet count closely. Withhold drug and notify physician if platelet
  • FUROSEMIDE (fur-oh’se-mide) Fumide , Furomide , Lasix, Luramide  Classifications: electrolytic and water balance agent; loop diuretic Pregnancy Category: C NURSING IMPLICATIONS Assessment & Drug Effects Observe patients receiving parenteral drug carefully; closely monitor BP and vital signs. Sudden death from cardiac arrest has been reported. Monitor BP during periods of
  • PIPERACILLIN SODIUM (pi-per’a-sill-in) Pipracil Classifications: antiinfective; beta-lactam antibiotic; antipseudomonal penicillin Prototype: Mezlocillin Pregnancy Category: B NURSING IMPLICATIONS Assessment & Drug Effects Obtain history of hypersensitivity to penicillins, cephalosporins, or other drugs prior to administration. Lab tests: C&S prior to first dose of the drug; start drug pending results. Periodic CBC
  • SPIRONOLACTONE (speer-on-oh-lak’tone) Aldactone, Novospiroton  Classifications: electrolytic and water balance agent; potassium-sparing diuretic Pregnancy Category: D NURSING IMPLICATIONS Assessment & Drug Effects Check blood pressure before initiation of therapy and at regular intervals throughout therapy. Lab tests: Monitor serum electrolytes (sodium and potassium) especially during early therapy; monitor digoxin
  • AMPICILLIN SODIUM AND SULBACTAM SODIUM (am-pi-sill’in/sul-bak’tam) Unasyn Classifications: antiinfective; antibiotic; aminopenicillin Prototype: Ampicillin Pregnancy Category: B NURSING IMPLICATIONS Assessment & Drug Effects Determine previous hypersensitivity reactions to penicillins, cephalosporins, and other allergens prior to therapy. Lab tests: Baseline C&S tests prior to initiation of therapy; start drug pending results. Report promptly unexplained

This entry was posted on Wednesday, September 26th, 2007 and is filed under Pharmacology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Subscribe by E-Mail or RSS

 
Get your copy now ! Use RSS. How? Click here.

Recent Forum Posts

Translator

Sponsors

Entrecard

Add Me

nursingcrib@yahoo.com